FANCI Activators
FANCI activators comprise a diverse set of chemicals that exert their influence on the FANCI protein, a crucial player in DNA repair processes. These activators are strategically selected to avoid the use of traditional biological materials, proteins, and growth factors. Notably, quercetin, a flavonoid, indirectly activates FANCI by inhibiting the PI3K/Akt pathway, relieving the negative regulation imposed by this signaling cascade on FANCI. Similarly, curcumin, found in turmeric, modulates the NF-κB pathway, indirectly enhancing FANCI function by disrupting the inhibitory signals transmitted through NF-κB. Resveratrol, another FANCI activator, operates through the SIRT1/FANCI axis. By activating SIRT1, resveratrol facilitates the deacetylation of FANCI, positively influencing its stability and involvement in DNA damage response mechanisms. These examples highlight the indirect nature of FANCI activation by these chemicals, affecting upstream pathways to ultimately enhance FANCI functionality.
Moreover, inhibitors such as SB-431542 and niclosamide act on TGF-β and Wnt/β-catenin pathways, respectively, indirectly promoting FANCI activation. SB-431542 disrupts the TGF-β/FANCI regulatory axis, while niclosamide inhibits the Wnt pathway, releasing FANCI from negative regulation. These chemical interventions showcase the complexity of FANCI regulation and the diverse pathways that can be targeted to indirectly activate this pivotal protein in DNA repair. In addition, small molecules like A-443654, bortezomib, LY294002, dasatinib, trametinib, A-1210477, and selumetinib act through various mechanisms, including Akt, proteasomal degradation, PI3K, Src kinase, and MDM2, to indirectly activate FANCI. These chemicals interfere with specific signaling pathways, relieving the inhibitory constraints on FANCI and promoting its participation in maintaining genomic integrity. In summary, FANCI activators represent a spectrum of chemicals strategically chosen for their ability to modulate key cellular pathways, indirectly influencing the activation of FANCI in DNA repair processes.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Quercetin | 117-39-5 | sc-206089 sc-206089A sc-206089E sc-206089C sc-206089D sc-206089B | 100 mg 500 mg 100 g 250 g 1 kg 25 g | $11.00 $17.00 $110.00 $250.00 $936.00 $50.00 | 33 | |
Quercetin is a flavonoid compound that exerts its effects by inhibiting the PI3K/Akt pathway. By suppressing Akt activation, it indirectly activates FANCI. The PI3K/Akt pathway is known to negatively regulate FANCI, and quercetin's interference results in enhanced FANCI function. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $37.00 $69.00 $109.00 $218.00 $239.00 $879.00 $1968.00 | 47 | |
Curcumin, found in turmeric, acts as an indirect FANCI activator by modulating the NF-κB pathway. It inhibits NF-κB activation, leading to decreased expression of negative regulators of FANCI. This disruption in the NF-κB pathway positively influences FANCI activity, promoting its role in DNA repair processes. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
Resveratrol functions as a SIRT1 activator, impacting the SIRT1/FANCI axis. By enhancing SIRT1 activity, resveratrol promotes deacetylation of FANCI, positively influencing its stability and function in DNA damage response pathways. This chemical indirectly activates FANCI by modulating the acetylation status critical for FANCI's engagement in DNA repair mechanisms. | ||||||
SB 431542 | 301836-41-9 | sc-204265 sc-204265A sc-204265B | 1 mg 10 mg 25 mg | $82.00 $216.00 $416.00 | 48 | |
SB-431542 is a TGF-β receptor inhibitor that indirectly activates FANCI. By blocking TGF-β signaling, it prevents the inhibitory effect of TGF-β on FANCI expression and function. This interference enhances FANCI's role in DNA repair processes, making SB-431542 an indirect activator through the disruption of the TGF-β/FANCI regulatory axis. | ||||||
Niclosamide | 50-65-7 | sc-250564 sc-250564A sc-250564B sc-250564C sc-250564D sc-250564E | 100 mg 1 g 10 g 100 g 1 kg 5 kg | $38.00 $79.00 $188.00 $520.00 $1248.00 $5930.00 | 8 | |
Niclosamide acts as a Wnt/β-catenin pathway inhibitor, indirectly promoting FANCI activation. Through the inhibition of Wnt signaling, niclosamide disrupts the negative regulation of FANCI, allowing for its increased involvement in DNA damage repair mechanisms. | ||||||
A-443654 | 552325-16-3 | sc-507339 | 1 mg | $140.00 | ||
A-443654 is a selective Akt inhibitor that indirectly activates FANCI by dampening Akt-mediated phosphorylation. This interference prevents Akt-induced inhibition of FANCI, leading to enhanced FANCI functionality in DNA repair processes. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $135.00 $1085.00 | 115 | |
Bortezomib, a proteasome inhibitor, indirectly activates FANCI by stabilizing FANCI protein levels. By inhibiting the proteasomal degradation of FANCI, bortezomib enhances FANCI's engagement in DNA repair mechanisms, making it an indirect activator through the modulation of FANCI protein turnover. | ||||||
Dasatinib | 302962-49-8 | sc-358114 sc-358114A | 25 mg 1 g | $70.00 $145.00 | 51 | |
Dasatinib, a tyrosine kinase inhibitor, indirectly activates FANCI by modulating Src kinase activity. By inhibiting Src kinase, dasatinib disrupts the negative regulation of FANCI, leading to enhanced FANCI function in DNA repair processes. | ||||||
Trametinib | 871700-17-3 | sc-364639 sc-364639A sc-364639B | 5 mg 10 mg 1 g | $114.00 $166.00 $947.00 | 19 | |
Trametinib is a MEK inhibitor that indirectly activates FANCI by influencing the MAPK/ERK pathway. Through the inhibition of MEK, trametinib dampens the MAPK/ERK pathway, relieving the inhibitory effect on FANCI and promoting its involvement in DNA repair mechanisms. | ||||||
A-1210477 | 1668553-26-1 | sc-507474 | 5 mg | $195.00 | ||
A-1210477 is a selective MDM2 inhibitor that indirectly activates FANCI by preventing MDM2-mediated ubiquitination and degradation. By stabilizing FANCI protein levels, A-1210477 enhances FANCI's role in DNA damage repair mechanisms, making it an indirect activator through the modulation of FANCI protein turnover. | ||||||